Table 1. Summary of cases included in the study.
Case | Gender | Age | Ethnicity | Treatment | Relapse | SG (months) | KIT |
---|---|---|---|---|---|---|---|
1 | Female | 69 | White | CX + RXT | Yes | 117 | Wild |
2 | Female | 66 | White | CX + RXT | Yes | 54 | Wild |
3 | Female | 38 | White | CX | Yes | 11 | Wild |
4 | Female | 88 | White | CX + RXT | Yes | Still Alive | Wild |
5 | Female | 64 | White | CX + RXT | No | Still Alive | Mutated |
6 | Female | 61 | White | CX + RXT | No | Still Alive | Wild |
7 | Female | 62 | White | CX + RXT | Yes | 27 | Wild |
8 | Female | 62 | White | CX | Yes | 29 | Wild |
9 | Female | 39 | White | CX + RXT | Yes | Still Alive | Wild |
10 | Female | 62 | White | CX | No | Still Alive | Wild |
11 | Female | 27 | White | CX | Yes | 10 | Wild |
12 | Female | 59 | White | CX | Yes | Still Alive | Wild |
13 | Female | 60 | White | CX | Yes | 8 | Wild |
14 | Female | 76 | White | CX | Yes | 11 | Wild |
15 | Female | 63 | White | CX | Yes | 14 | Wild |
16 | Female | 69 | White | CX | Yes | 14 | Wild |
17 | Male | 32 | White | CX + RXT | Yes | 19 | Wild |
18 | Male | 85 | White | CX + RXT | Yes | 43 | Wild |
19 | Male | 47 | White | CX | No | Still Alive | Wild |
20 | Male | 39 | White | CX + RXT | Yes | 64 | Wild |
21 | Male | 53 | White | CX + RXT | Yes | 99 | Mutated |
22 | Male | 52 | White | CX + RXT | Yes | Still Alive | Mutated |
23 | Male | 62 | White | CX + RXT | Yes | 27 | Wild |
24 | Male | 51 | White | CX + RXT | No | Still Alive | Wild |
25 | Male | 40 | White | CX + RXT | Yes | 15 | Mutated |
26 | Male | 81 | Black | CX | Yes | 60 | Mutated |
27 | Male | 69 | Black | CX + RXT | Yes | 21 | Mutated |
28 | Male | 76 | Black | CX + RXT | Yes | 11 | Mutated |
CX + RXT = Surgical resection followed by adjuvante radiotherapy, CX = Exclusive surgical resection, OS = Overall survival.